Pathophysiology of REM sleep behaviour disorder
Brain Communications · 2026-10-31 · 8 (6)
DOI: 10.1093/braincomms/fcag388 ↗Abstract
Abstract REM sleep behaviour disorder (RBD) is a parasomnia characterized by loss of muscle atonia and dream enactment behaviour during REM sleep. RBD is recognized as a significant prodromal marker of α-synucleinopathies, but characterizing its unique neuropathological features is challenging due to reliance on individual case reports. Additionally, RBD is not a terminal illness, and data generalisability is limited by the high co-occurrence of α-synucleinopathies. In this review, we discuss the mechanisms responsible for altered REM sleep regulation in RBD, incorporating evidence from human post-mortem histological analyses, structural and functional neuroimaging data on patients with RBD, and pharmacological studies. We explore the risks, biomarkers, and mechanisms of phenoconversion from RBD to α-synucleinopathies, drawing on data from large longitudinal patient cohorts, and we consider disease remission. Lastly, we propose several promising directions for future studies.
EUVIMED